Gilead Sciences, Inc v. Cipla Ltd

Court

District Court, D. Delaware (D. Del.)
Official Court Website →

Assigned judge

Unassigned Judge · 2,770 cases in index

Docket number

1:26-cv-00149

Cause

35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement

Nature of suit

835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.

Jurisdiction

Federal Question

Jury demand

None

Date filed

02/10/2026

1,113 Patent - ANDA cases in this court are indexed here.

Parties

• plaintiff · Gilead Sciences, Inc Pharmaceuticals & Biotechnology · 97 cases
• defendant · Cipla Ltd · 25 cases

Part of a Larger Litigation Pattern

This is one of 26 Patent - ANDA cases in our index naming Cipla Ltd — a possible mass-tort or coordinated-litigation cluster.

• Exelixis, Inc v. Cipla Ltd
  District Court, D. DelawareFiled 05/09/2024
• Bayer Pharma Ag v. Cipla Ltd
  District Court, D. DelawareFiled 10/20/2023
• Exelixis, Inc v. Cipla Ltd
  District Court, D. DelawareFiled 03/16/2023
• Actelion Pharmaceuticals US, Inc v. Cipla Ltd
  District Court, D. DelawareFiled 11/03/2022
• Cipla Ltd v. Boehringer Ingelheim Pharmaceuticals Inc
  District Court, D. DelawareFiled 03/04/2022
• Pfizer Inc v. Cipla, Ltd
  District Court, D. DelawareFiled 10/16/2020

About Patent - ANDA Lawsuits

ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

Frequently Asked Questions

What is Gilead Sciences, Inc v. Cipla Ltd?

Gilead Sciences, Inc v. Cipla Ltd is a federal patent - anda lawsuit filed on 02/10/2026 in the District Court, D. Delaware. The case is currently open in the federal court system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What type of case is this?

It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What court is the case in?

The case is in the District Court, D. Delaware, docket number 1:26-cv-00149.

When was the case filed?

Gilead Sciences, Inc v. Cipla Ltd was filed on 02/10/2026. The case is currently open.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.